A BILL 
To provide for digital communication of prescribing informa-
tion for drugs (including biological products), and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Prescription Informa-
4
tion Modernization Act of 2022’’. 
5
23:47 Apr 21, 2022
H7559
2 
•HR 7559 IH
SEC. 2. DIGITAL COMMUNICATION OF FDA-APPROVED PRE-
1
SCRIBING INFORMATION FOR DRUGS (IN-
2
CLUDING BIOLOGICAL PRODUCTS). 
3
(a) IN GENERAL.—Section 502(f) of the Federal 
4
Food, Drug, and Cosmetic Act (21 U.S.C. 352(f)) is 
5
amended by adding at the end the following: ‘‘Required 
6
prescribing information for drugs subject to section 
7
503(b)(1) may be made available solely by electronic 
8
means provided that the labeling complies with all applica-
9
ble requirements of law, that the manufacturer affords 
10
prescribers and dispensers the opportunity to elect to also 
11
continue to receive all such information in paper form, or 
12
to request paper labeling on an as-needed basis, and after 
13
such request, and that the manufacturer promptly pro-
14
vides the requested information without additional cost.’’. 
15
(b) RULEMAKING.— 
16
(1) IN GENERAL.—Not later than 1 year after 
17
the date of the enactment of this Act, the Secretary 
18
of Health and Human Services shall issue final reg-
19
ulations to— 
20
(A) implement the amendment made by 
21
subsection (a); and 
22
(B) provide instructions on how health 
23
care professionals can receive paper copies of 
24
prescribing information directly from the manu-
25
facturer or distributor if desired. 
26
23:47 Apr 21, 2022
H7559
3 
•HR 7559 IH
(2) ECONOMIC
IMPACTS.—The Secretary of 
1
Health and Human Services shall design the regula-
2
tions required by paragraph (1) so as to minimize 
3
the adverse economic impacts of such regulations on 
4
prescribers and dispensers. 
5
(c) PUBLIC WORKSHOP.—Not later than 2 years 
6
after the date of the enactment of this Act, the Secretary 
7
of Health and Human Services, acting through the Com-
8
missioner of Food and Drugs, shall hold a public workshop 
9
with relevant stakeholders to discuss how to continue to 
10
optimize the format, accessibility, and usability of pre-
11
scribing information. 
12
(d) EFFECTIVE DATE.—The amendment made by 
13
subsection (a) shall apply with respect to drugs introduced 
14
or delivered for introduction into interstate commerce on 
15
or after the sooner of— 
16
(1) the date that is 2 years after the date of the 
17
enactment of this Act; or 
18
(2) the effective date of the final regulations 
19
promulgated to implement such amendment. 
20
(e) DEFINITION.—In this section, the term ‘‘drug’’ 
21
has the meaning given to such term in section 201 of the 
22
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321). 
23
Æ 
23:47 Apr 21, 2022
H7559
